Clinical Trial Detail

NCT ID NCT01737502
Title PKCi and mTOR Inhibition With Auranofin+Sirolimus for Squamous Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Mayo Clinic

lung small cell carcinoma

lung adenocarcinoma

lung squamous cell carcinoma


Auranofin + Sirolimus

Age Groups: adult

Additional content available in CKB BOOST